Topic: MS

Disease-modifying therapies in MS: long-term data

May 10, 2017  

AAN 2017 DAILY REPORT

April 27, 2017  

MS Sequencing: Part 4 – What is the treatment plan?

April 19, 2017  

FDA approves ocrelizumab in RRMS, PPMS

March 30, 2017  

Neurologists cautious about patient e-contact: survey

March 15, 2017  

Daclizumab approved in Canada for relapsing MS

March 3, 2017  

MS Sequencing: Part 3 – Evaluating treatment response

February 16, 2017  

NEUROSOUND: CHARCOT 2016 HIGHLIGHTS

January 25, 2017  

MS Sequencing: Part 2 – Treatment initiation

January 12, 2017  

Sun avoidance – more harm than good?

December 16, 2016